Cirrhosis is under‐recognised in patients subsequently diagnosed with hepatocellular cancer
Open Access
- 19 January 2016
- journal article
- research article
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 43 (5), 621-630
- https://doi.org/10.1111/apt.13505
Abstract
Background Most clinical practice guidelines recommend screening for HCC in patients with cirrhosis. However, patients with compensated cirrhosis are often asymptomatic and may remain unrecognised for years. Aims To determine the extent to which cirrhosis is unrecognised in a US Veteran population with HCC, and to evaluate the association between lack of cirrhosis recognition and stage of HCC at diagnosis. Methods We reviewed the electronic medical records of a random sample of HCC cases diagnosed in the national Veterans Affairs system between 2005 and 2011. We conducted multivariable analyses adjusting for patients’ demographics, comorbidity, aetiology of underlying disease and healthcare utilisation including HCC surveillance. Results Of 1201 patients with HCC and cirrhosis, 24.6% had unrecognised cirrhosis prior to HCC diagnosis. Older patients [>65 years, odds ratio (OR) 2.32], African Americans (OR 1.93), patients with alcoholic or NAFLD liver disease (OR 1.69 and 4.77 respectively), HIV (OR 3.02), and fewer comorbidities (Deyo 0 vs. 3, OR 2.42) had significantly higher odds of having unrecognised cirrhosis than comparison groups. Furthermore, patients with unrecognised cirrhosis were 6.5 times more likely to have advanced stage HCC at diagnosis. The effect of cirrhosis recognition on HCC stage remained significant after adjusting for pre‐specified covariates (OR 3.37). Conclusions In one quarter of patients, cirrhosis was unrecognised prior to HCC diagnosis, and this group was significantly more likely to have advanced stage HCC. These findings emphasise the importance of timely evaluation for cirrhosis in at‐risk populations as a critical step to improving outcomes for patients with HCC.Keywords
Funding Information
- National Cancer Institute (R01 CA160738)
This publication has 30 references indexed in Scilit:
- Comparative diagnostic accuracy of magnetic resonance elastography vs. eight clinical prediction rules for non‐invasive diagnosis of advanced fibrosis in biopsy‐proven non‐alcoholic fatty liver disease: a prospective studyAlimentary Pharmacology & Therapeutics, 2015
- Suboptimal Surveillance for and Knowledge of Hepatocellular Carcinoma Among Primary Care ProvidersClinical Gastroenterology and Hepatology, 2014
- Hepatitis C in the United StatesNew England Journal of Medicine, 2013
- Association Between Nonalcoholic Fatty Liver Disease and Risk for Hepatocellular Cancer, Based on Systematic ReviewClinical Gastroenterology and Hepatology, 2012
- Failure Rates in the Hepatocellular Carcinoma Surveillance ProcessCancer Prevention Research, 2012
- Loco-regional treatment of hepatocellular carcinomaHepatology, 2010
- Race, ethnicity, and socioeconomic status influence the survival of patients with hepatocellular carcinoma in the United StatesCancer, 2010
- Hepatocellular carcinomas in patients with metabolic syndrome often develop without significant liver fibrosis: A pathological analysisHepatology, 2008
- The NAFLD fibrosis score: A noninvasive system that identifies liver fibrosis in patients with NAFLDHepatology, 2007
- Prognosis of Hepatocellular Carcinoma: The BCLC Staging ClassificationSeminars in Liver Disease, 1999